Ohio State trial examines whether probiotics reduce ovarian cancer treatment side effects

Researchers at The Ohio State University Comprehensive Cancer Center are conducting a clinical trial to evaluate whether probiotic supplements can help ovarian cancer patients tolerate chemotherapy. EurekAlert! reported that the study is taking place at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Columbus, Ohio. [1]

According to EurekAlert!, the trial aims to determine if improving gut health can ease common chemotherapy symptoms, including nausea, fatigue, and other digestive issues. Investigators are also testing whether taking a probiotic during treatment can ultimately improve how well the chemotherapy works against the cancer. [1]

Chemotherapy treatments often cause severe side effects that disrupt treatment schedules or reduce patient quality of life. As FTMQ Health reported earlier, medical interventions during cancer treatment frequently focus on preserving long-term health outcomes and mitigating the damaging impacts of cancer therapies. [1][2]

The clinical trial is currently actively evaluating eligible patients receiving chemotherapy for ovarian cancer in Ohio. EurekAlert! reported that researchers hope the findings will establish whether supporting the gut microbiome is an effective strategy for managing treatment toxicity. [1]